Tazarotene Patent Expiration

Tazarotene is Used for treating acne vulgaris in patients 12 years of age or older. It was first introduced by Allergan Inc in its drug Tazorac on Jun 13, 1997. Other drugs containing Tazarotene are Fabior, Arazlo, Avage. 8 different companies have introduced drugs containing Tazarotene.


Tazarotene Patents

Given below is the list of patents protecting Tazarotene, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Arazlo US11311482 Topical compositions and methods for treating skin diseases May 11, 2038 Bausch
Arazlo US11679116 Topical compositions and methods for treating psoriasis Jun 06, 2036 Bausch
Fabior US10568859 Topical foam composition Feb 24, 2030 Mayne Pharma
Fabior US10688071 Topical foam composition Feb 24, 2030 Mayne Pharma
Fabior US8808716 Topical foam composition Feb 24, 2030 Mayne Pharma
Arazlo US6517847 Topical gel delivery system Aug 03, 2020

(Expired)

Bausch
Tazorac US5914334 Stable gel formulation for topical treatment of skin conditions Jun 07, 2014

(Expired)

Allergan
Tazorac US6258830 Stable gel formulation for topical treatment of skin conditions Jun 07, 2014

(Expired)

Allergan



Tazarotene's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Tazarotene Generic API Manufacturers

Several generic applications have been filed for Tazarotene. The first generic version for Tazarotene was by Taro Pharmaceuticals Inc and was approved on Apr 3, 2017. And the latest generic version is by Padagis Israel Pharmaceuticals Ltd and was approved on Jul 15, 2024.

Given below is the list of companies who have filed for Tazarotene generic, along with the locations of their manufacturing plants worldwide.


1. COSETTE

Cosette Pharmaceuticals Inc has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Cosette.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

gel Prescription TOPICAL AB Sep 13, 2022
0.05%

gel Prescription TOPICAL AB Sep 13, 2022


Manufacturing Plant Locations
New

Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.

Country City Firm Name
United States
South Plainfield Cosette Pharmaceuticals, Inc.
Lincolnton Cosette Pharmaceuticals NC Laboratories, LLC





2. FOUGERA PHARMS INC

Fougera Pharmaceuticals Inc has filed for 1 generic for Tazarotene. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

cream Discontinued TOPICAL N/A Jan 28, 2019





3. PADAGIS ISRAEL

Padagis Israel Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Padagis Israel.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

gel Prescription TOPICAL AB Apr 25, 2023
0.05%

cream Prescription TOPICAL AB Jul 15, 2024


Manufacturing Plant Locations
New

Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.

Country City Firm Name
Israel
Yerucham Padagis Israel Pharmaceuticals Ltd.





4. SOLARIS PHARMA CORP

Solaris Pharma Corp has filed for 2 different strengths of generic version for Tazarotene. Given below are the details of the strengths of this generic introduced by Solaris Pharma Corp.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

gel Prescription TOPICAL AB Mar 20, 2023
0.05%

gel Prescription TOPICAL AB Mar 20, 2023


Manufacturing Plant Locations
New

Solaris Pharma Corp's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Solaris Pharma Corp as present at those locations.

Country City Firm Name
United States
Bridgewater Solaris Pharma Corp





5. TARO

Taro Pharmaceuticals Inc has filed for 1 generic for Tazarotene. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
0.1%

cream Prescription TOPICAL AB Apr 3, 2017


Manufacturing Plant Locations
New

Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.

Country City Firm Name
United States
Honolulu Taro Delight, LLC
Hawthorne Taro Pharmaceuticals U.S.A., Inc.
Israel
Haifa Taro Pharmaceutical Industries, Ltd.
Canada
Brampton Taro Pharmaceuticals Inc.